BRIEF-Cipher Pharmaceuticals announces approvals of SD Cream and AD Cream

Wed Apr 6, 2016 4:07pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 6 (Reuters) - Cipher Pharmaceuticals Inc

* Cipher Pharmaceuticals announces approvals of astion acquired barrier creams by Health Canada and the Medicines Evaluation Board

* Says in addition European approval of helioclin pruritus SD cream (also known as pruridexin) was achieved

* In Canada , Cipher plans to market products through its internal sales team

* Says company expects to out-license helioclin pruritus sd cream and helioclin dermatitis SD cream in Europe Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)